<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE Annotation PUBLIC "-//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN" "../GENIAtypes/GENIA_event_20.dtd">
<Annotation created="04/03/2006" creator="Junko Matsuura" annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=7912114">
<PubmedArticleSet>
<PubmedArticle>
<MedlineCitation>
<PMID>7912114</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term sem="Organic_compound_other" id="T1" lex="pentoxifylline">Pentoxifylline</term> for the treatment of infection with <term sem="Virus" id="T2" lex="human_immunodeficiency_virus">human immunodeficiency virus</term>.</sentence>
<event id="E1">
<type class="Initiation_of_viral_infection" />
<theme idref="T2" />
<clue>Pentoxifylline for the treatment of <clueType>infection</clueType> <linkTheme>with</linkTheme> human immunodeficiency virus.</clue>
</event>
<event id="E2">
<type class="Artificial_process" />
<theme idref="T1" />
<clue>Pentoxifylline <linkCause>for</linkCause> the <clueType>treatment</clueType> of infection with human immunodeficiency virus.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2"><term sem="Protein_molecule" id="A1">Cytokine</term> dysregulation in <term sem="Other" id="T3" lex="human_immunodeficiency_virus_type_1_(HIV-1)_infection"><term sem="Virus" id="T4" lex="human_immunodeficiency_virus_type_1">human immunodeficiency virus type 1</term> (<term sem="Virus" id="T5" lex="HIV-1">HIV-1</term>) infection</term> has been documented in numerous studies and has been cited as an important component in the pathogenesis of this <term sem="Other" id="T6" lex="retroviral_infection">retroviral infection</term>.</sentence>
<event id="E3">
<type class="Initiation_of_viral_infection" />
<theme idref="T5" />
<clue>Cytokine dysregulation in human immunodeficiency virus type 1 (HIV-1) <clueType>infection</clueType> has been documented in numerous studies and has been cited as an important component in the pathogenesis of this retroviral infection.</clue>
</event>
<event id="E4">
<type class="Regulation" />
<theme idref="A1" />
<cause idref="E3" />
<clue>Cytokine <clueType>dysregulation</clueType> <linkCause>in</linkCause> human immunodeficiency virus type 1 (HIV-1) infection has been documented in numerous studies and has been cited as an important component in the pathogenesis of this retroviral infection.</clue>
</event>
<event id="E105">
<type />
<cause idref="E3" />
<clue>Cytokine dysregulation in human immunodeficiency virus type 1 (HIV-1) infection has been documented in numerous studies and has been cited as an important component in the <clueType>pathogenesis</clueType> <linkCause>of</linkCause> <corefTheme>this retroviral infection</corefTheme>.</clue>
<comment>SOO</comment>
</event>
<event id="E5">
<type class="Correlation" />
<theme idref="E4" />
<theme idref="E105" />
<clue>Cytokine dysregulation in human immunodeficiency virus type 1 (HIV-1) infection has been documented in numerous studies and has been cited as an <clueType>important component</clueType> <linkTheme>in</linkTheme> the pathogenesis of this retroviral infection.</clue>
</event>
<sentence id="S3">Pharmacological modification of <term sem="Other" id="T7" lex="cytokine_dysregulation"><term sem="Protein_family_or_group" id="T8" lex="cytokine">cytokine</term> dysregulation</term>, therefore, has been suggested as a <term sem="Other" id="T9" lex="therapeutic_modality">therapeutic modality</term> for <term sem="Other" id="T10" lex="HIV-1_infection"><term sem="Virus" id="T11" lex="HIV-1">HIV-1</term> infection</term>.</sentence>
<event id="E51">
<type class="Initiation_of_viral_infection" />
<theme idref="T11" />
<clue>Pharmacological modification of cytokine dysregulation, therefore, has been suggested as a therapeutic modality for HIV-1 <clueType>infection</clueType>.</clue>
</event>
<event id="E52">
<type class="Regulation" />
<theme idref="T8" />
<clue>Pharmacological modification of cytokine <clueType>dysregulation</clueType>, therefore, has been suggested as a therapeutic modality for HIV-1 infection.</clue>
</event>
<event id="E53">
<type class="Regulation" />
<theme idref="E52" />
<clue><clueType>Pharmacological modification</clueType> <linkTheme>of</linkTheme> cytokine dysregulation, therefore, has been suggested as a therapeutic modality for HIV-1 infection.</clue>
</event>
<sentence id="S4">Dr. Dezube of Beth Israel Hospital (Boston) concisely reviews the state of our knowledge regarding the effects of <term sem="Organic_compound_other" id="T12" lex="pentoxifylline">pentoxifylline</term> on expression of <term sem="Protein_molecule" id="T13" lex="tumor_necrosis_factor-alpha">tumor necrosis factor-alpha</term>, a <term sem="Protein_family_or_group" id="T14" lex="cytokine">cytokine</term> known to influence <term sem="Other" id="T15" lex="HIV-1_replication"><term sem="Virus" id="T16" lex="HIV-1">HIV-1</term> replication</term> and to play a possible role in the <term sem="Other" id="A5"><term sem="Other" id="A4">clinical manifestations</term> of advanced infection with this virus</term>.</sentence>
<event id="E8">
<type class="Gene_expression" />
<theme idref="T13" />
<clue>Dr. Dezube of Beth Israel Hospital (Boston) concisely reviews the state of our knowledge regarding the effects of pentoxifylline on <clueType>expression</clueType> <linkTheme>of</linkTheme> tumor necrosis factor-alpha, a cytokine known to influence HIV-1 replication and to play a possible role in the clinical manifestations of advanced infection with this virus.</clue>
</event>
<event id="E9">
<type class="Regulation" />
<theme idref="E8" />
<cause idref="T12" />
<clue>Dr. Dezube of Beth Israel Hospital (Boston) concisely reviews the state of our knowledge regarding the <clueType>effects</clueType> <linkCause>of</linkCause> pentoxifylline <linkTheme>on</linkTheme> expression of tumor necrosis factor-alpha, a cytokine known to influence HIV-1 replication and to play a possible role in the clinical manifestations of advanced infection with this virus.</clue>
</event>
<event id="E64">
<type class="Viral_life_cycle" />
<theme idref="T16" />
<clue>Dr. Dezube of Beth Israel Hospital (Boston) concisely reviews the state of our knowledge regarding the effects of pentoxifylline on expression of tumor necrosis factor-alpha, a cytokine known to influence HIV-1 <clueType>replication</clueType> and to play a possible role in the clinical manifestations of advanced infection with this virus.</clue>
</event>
<event id="E65">
<type class="Regulation" />
<theme idref="E64" />
<cause idref="T13" />
<clue>Dr. Dezube of Beth Israel Hospital (Boston) concisely reviews the state of our knowledge regarding the effects of pentoxifylline on expression of tumor necrosis factor-alpha, a cytokine known to <clueType>influence</clueType> HIV-1 replication and to play a possible role in the clinical manifestations of advanced infection with this virus.</clue>
</event>
<event id="E66">
<type class="Initiation_of_viral_infection" />
<theme idref="T16" />
<clue>Dr. Dezube of Beth Israel Hospital (Boston) concisely reviews the state of our knowledge regarding the effects of pentoxifylline on expression of tumor necrosis factor-alpha, a cytokine known to influence HIV-1 replication and to play a possible role in the clinical manifestations of <clueType>advanced infection</clueType> <linkTheme>with</linkTheme> <corefTheme>this virus</corefTheme>.</clue>
</event>
<event id="E67">
<type class="Regulation" />
<theme idref="A5" />
<cause idref="T13" />
<clue>Dr. Dezube of Beth Israel Hospital (Boston) concisely reviews the state of our knowledge regarding the effects of pentoxifylline on expression of tumor necrosis factor-alpha, a cytokine known to influence HIV-1 replication and to <clueType>play</clueType> a possible <clueType>role</clueType> <linkTheme>in</linkTheme> the clinical manifestations of advanced infection with this virus.</clue>
<comment>TPS: A5</comment>
</event>
<sentence id="S5"><term sem="Organic_compound_other" id="T17" lex="pentoxifylline">Pentoxifylline</term>, a <term sem="Organic_compound_other" id="T18" lex="trisubstituted_xanthine_derivative">trisubstituted xanthine derivative</term>, has been used to decrease <term sem="Other" id="T19" lex="blood_viscosity">blood viscosity</term> and is reasonably well tolerated by most recipients of the drug.</sentence>
<event id="E14">
<type class="Negative_regulation" />
<theme idref="T19" />
<cause idref="T17" />
<clue>Pentoxifylline, a trisubstituted xanthine derivative, has been used to <clueType>decrease</clueType> blood viscosity and is reasonably well tolerated by most recipients of the drug.</clue>
</event>
<sentence id="S6">Results of preliminary studies, many of which were conducted by <term sem="Multicellular_organism_natural" id="T20" lex="Dr._Dezube">Dr. Dezube</term>, suggest that use of this agent in combination with <term sem="Organic_compound_other" id="A6">antiretroviral compounds</term> may prove useful in the treatment of <term sem="Multicellular_organism_natural" id="T21" lex="patient">patients</term> with <term sem="Virus" id="T22" lex="HIV-1">HIV-1</term> infection.</sentence>
<event id="E15">
<type class="Initiation_of_viral_infection" />
<theme idref="T22" />
<clue>Results of preliminary studies, many of which were conducted by Dr. Dezube, suggest that use of this agent in combination with antiretroviral compounds may prove useful in the treatment of patients with HIV-1 <clueType>infection</clueType>.</clue>
</event>
<event id="E68">
<type class="Artificial_process" />
<theme idref="T17" />
<theme idref="A6" />
<clue>Results of preliminary studies, many of which were conducted by Dr. Dezube, suggest that <clueType>use</clueType> <linkTheme>of</linkTheme> <corefTheme idref1="T17">this agent</corefTheme> <linkTheme>in combination with</linkTheme> antiretroviral compounds may prove useful in the treatment of patients with HIV-1 infection.</clue>
</event>
</AbstractText>
</Abstract>
</Article>
</MedlineCitation>
</PubmedArticle>
</PubmedArticleSet>
</Annotation>
